David A. Siegel Uni Qure N.V. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Uni Qure N.V. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 659,700 shares of QURE stock, worth $42.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
659,700
Previous 668,494
1.32%
Holding current value
$42.2 Million
Previous $7.09 Million
29.78%
% of portfolio
0.02%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding QURE
# of Institutions
187Shares Held
51.8MCall Options Held
4.43MPut Options Held
1.27M-
Rtw Investments, LP New York, NY5.16MShares$330 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$255 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$237 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$232 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$176 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $2.99B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...